Our results showing an upregulation of Chi3l1 in EAE microglia are consistent with two studies showing that microglia from MS patients express more CHI3L1 compared to microglia derived from control patients [21,22]. This evidence concerns the gene CHI3L1 and myeloid sarcoma.